Literature DB >> 7801960

Diagnosis of hypertensive end-stage renal disease: effect of patient's race.

T V Perneger1, P K Whelton, M J Klag, K A Rossiter.   

Abstract

The authors conducted a simulation study to examine whether the race of a patient with end-stage renal disease (ESRD) influences the diagnosis of underlying kidney disease made by the nephrologist. The hypothesis was that ESRD may be more readily ascribed to hypertension in blacks than in whites. Nephrologists practicing in Maryland during 1991 were sent written case histories based on the presentation of seven patients with ESRD. For each case history, the patient's race was randomly assigned to be "black" or "white." The nephrologist's diagnosis of underlying renal disease was recorded as "hypertensive" or "other." Analysis of 197 case histories from 58 physicians (81% of those eligible) was performed using logistic regression. The distribution of underlying causes of ESRD in the case histories was similar to national statistics: hypertensive ESRD, 34%; diabetic ESRD, 30%; glomerulonephritis, 11%; other, 16%; unknown, 10%. Case histories that identified the patient's race as black were more likely (odds ratio = 1.97; 95% confidence interval 1.05-3.68) to result in a diagnosis of hypertensive ESRD than case histories in which the patient's race was said to be white, after adjustment for case history. Analyses that accounted for the physicians' individual tendencies to diagnose hypertensive ESRD yielded similar results. These findings suggest that black ESRD patients may be more likely to be labeled as having hypertensive kidney disease than white ESRD patients with similar clinical histories. Using race as a criterion to establish diagnoses of kidney disease may obscure the interpretation of incidence statistics, affect the management of individual patients, and hinder epidemiologic studies of risk factors for kidney failure. Definition of clear diagnostic criteria for the underlying cause of kidney failure is highly desirable.

Entities:  

Mesh:

Year:  1995        PMID: 7801960     DOI: 10.1093/oxfordjournals.aje.a117338

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

Review 1.  Target organ damage in African American hypertension: role of APOL1.

Authors:  Barry I Freedman; Mariana Murea
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

2.  Defining incident chronic kidney disease in the research setting: The ARIC Study.

Authors:  Lori D Bash; Josef Coresh; Anna Köttgen; Rulan S Parekh; Tibor Fulop; Yaping Wang; Brad C Astor
Journal:  Am J Epidemiol       Date:  2009-06-17       Impact factor: 4.897

Review 3.  The spectrum of MYH9-associated nephropathy.

Authors:  Meredith A Bostrom; Barry I Freedman
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

4.  Need to Reclassify Etiologies of ESRD on the CMS 2728 Medical Evidence Report.

Authors:  Bryan M Tucker; Barry I Freedman
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-17       Impact factor: 8.237

5.  Hypertensive cardiovascular disease in African Americans.

Authors:  R K Wali; M R Weir
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

6.  Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria.

Authors:  C I Obialo; K Hewan-Lowe
Journal:  J Natl Med Assoc       Date:  1998-11       Impact factor: 1.798

Review 7.  Hypertension and chronic kidney disease: controversies in pathogenesis and treatment.

Authors:  J L Pirkle; B I Freedman
Journal:  Minerva Urol Nefrol       Date:  2013-03       Impact factor: 3.720

Review 8.  Essential hypertension and risk of nephropathy: a reappraisal.

Authors:  Mariana Murea; Barry I Freedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

Review 9.  Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures.

Authors:  Barry I Freedman; Jasmin Divers; Nicholette D Palmer
Journal:  Am J Kidney Dis       Date:  2013-07-26       Impact factor: 8.860

10.  Renal failure among male Hispanics in the United States.

Authors:  A P Chiapella; H I Feldman
Journal:  Am J Public Health       Date:  1995-07       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.